Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Megan S. Lim, MD, PhD

Megan S. Lim, MD, PhD Physician

Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Dr. Lim is employed by Penn Medicine.

No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Clinical Specialties


  • Pathology and Laboratory Medicine

Programs & Centers:

Board Certification:

  • Pathology - Anatomic Pathology, 1993
  • Pathology - Hematology, 1999
  • Pathology - Molecular Genetic Pathology, 2003

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of Calgary
Residency: University of Calgary
Fellowship: National Cancer Institute


A. J. French Society, Local American Association for Cancer Research, National American Biologic Resources and Facilities, National American Society for Clinical Pathology, National American Society for Investigative Pathology, National American Society of Hematology, National Association for Molecular Pathology, International Canadian Association of Pathologists, National Children’s Oncology Group, International College of American Pathologists, National Department of Defense Congressionally Directed Medical Research Programs (CDMRP), National Lymphoma Research Foundation, National Michigan Society of Pathologists, Local NIH Lymphoma and Leukemia Molecular Profiling Project Grant, National Royal College of Physicians and Surgeons of Canada, National Society for Hematopathology/European Association for Haemotopathology, International St. Baldrick's Foundation, National United States and Canadian Academy of Pathology, International

Hospital Affiliation

Dr. Lim is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Fajgenbaum DC, Oksendhendler E, Casper C, Uldrick, T, Kurzrock R, Yoshizaki K, Nasta S, Rossi JF, Wong R, Simpson D, Sato Y, Terriou L, Ferrero S, Zinzani PL, Hoffman C, Goodman A, Krymskaya V, Elenitoba-Johnson KSJ, Lim MS, Chadburn A, Penmaraju N, Leitch H, Jaffe ES, Jayanthan R, Chandrasakan S, Lechowicz MJ, Ruth J, Greenway A, Stone K, Shilling D, Mukherjee S, Partridge HL, Pierson SK, Streetly M, Schey S, Munshi N, Ide M, Srkalovic G, Fossa A, Dispenzieri A, Voorhees P, van Rhee F.: International, Evidence-based Consensus Treatment Guidelines for the Management of Idiopathic Multicentric Castleman Disease. Blood : 2018.

168., Nam SJ, Kim S, Kwon D, Kim H, Kim S, Lee E, Kim TM, Heo KS, Park SH, Lim MS, Kim CW, Jeon YK.: Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system. Oncoimmunology 13 (7): 2018.

Bhatti M, Ippolito T, Mavis C, Gu J, Cairo MS, Lim MS, Hernandez-Ilizaliturri F, Barth MJ: Pre-clinical activity of targeting the PI3K/Akt/m TOR pathway in Burkitt lymphoma Oncotarget 9 (31): 21820-21830,2018.

Van Arnam JS, Lim MS, Elenitoba-Johnson KSJ: Novel Insights into the pathogenesis of T-cell Lymphomas Blood 11 : 2018.

Prokoph N, Larose H, Lim MS, Burke GAA, Turner SD.: Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond. Cancers (Basel) 10 (4): 2018.

Wu D, Lim MS, Jaffe ES.: Pathology of Castleman Disease Hematol Oncol Clin North Am 32 (1): 37-52,2018.

Udager AM, McHugh JB, Goudsmit CM, Weigelin HC, Lim MS, Elenitoba-Johnson KSJ, Betz BL, Carey TE, Brown NA.: Human Papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas Annals of Oncol. : 2017.

Elenitoba-Johnson KSJ, Lim MS: New Insights into Lymphoma Pathogenesis Annu Rev Pathol : 2017.

Mosse YP, Voss SD, Lim MS, Rolland DCM, Minard CG, Fox E, Adamson PC, Wilner K, Blaney SM, Weigel B.: Targeting ALK with Cizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. J Clin Oncol 35 (28): 3215-3221,2017.

Önder Ö, Rolland DCM, Yuan Z-F, Garcia BA, Lim MS and Elenitoba-Johnson KSJ: Poster presentation "Characterization of Histone Post-Translational Modifications of Cutaneous T-cell Lymphomas" 65thAmerican Society for Mass Spectrometry Conference on Mass Spectrometry & Allied Topics : 2017.

Academic Contact Info

Department of Pathology and Laboratory Medicine
Stellar Chance Office Suite 609C
422 Curie Blvd.

Philadelphia, PA 19104
Phone: (215) 898-4719
Patient appointments: 800-789-7366 (PENN)